# Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure

> **NCT00435162** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 74 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan 0.25 mg/kg
- **DRUG:** Valsartan 1.0 mg/kg
- **DRUG:** Valsartan 4.0 mg/kg

## Key facts

- **NCT ID:** NCT00435162
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2011-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435162, "Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00435162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*